Search
Patexia Research
Case number 1:23-cv-00975

United Therapeutics Corporation v. Liquidia Technologies, Inc. > Documents

Date Field Doc. No.Description (Pages)
Jul 2, 2024 102 NOTICE requesting Clerk to remove Brittany Cazakoff as co-counsel.. (DiBenedetto, Emily) (Entered: 07/02/2024) (1)
Jun 28, 2024 101 NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.'s Objections and Responses to Plaintiff United Therapeutics Corporation's First Set of Requests for Production (Nos. 1 - 17) filed by Liquidia Technologies, Inc..(Keller, Karen) (Entered: 06/28/2024) (2)
Jun 17, 2024 100 NOTICE OF SERVICE of Plaintiff's Responses and Objections to Defendant's First Set of Requests for Production (Nos. 1-75) - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 06/17/2024) (3)
Jun 13, 2024 99 NOTICE OF SERVICE of UTC's Opening Claim Construction Brief - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 06/13/2024) (3)
Jun 6, 2024 98 NOTICE OF SERVICE of 1. Defendant Liquidia Technologies, Inc's Objections and Responses to Plaintiff United Therapeutics Corporations First Set of Interrogatories (No. 1) 2. Defendant's First Set of Interrogatories to Plaintiff (Nos. 1 - 6) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 06/06/2024) (2)
Jun 4, 2024 97 NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.'s Initial Invalidity Contentions filed by Liquidia Technologies, Inc..(Keller, Karen) (Entered: 06/04/2024) (2)
May 31, 2024 96 MEMORANDUM ORDER: Plaintiff's motion for preliminary injunction (D.I. 25 ) is DENIED (see Memorandum Order for further details). Ordered by Judge Richard G. Andrews on 5/31/2024. (nms) (Entered: 05/31/2024) (30)
May 28, 2024 95 NOTICE OF SERVICE of Plaintiff's First Set Of Requests For Production Of Documents And Things To Liquidia Technologies, Inc. (Nos. 1-17) - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 05/28/2024) (3)
May 23, 2024 93 MOTION to Supplement the Record with Delaware District Court Decision in Baxalta v. Genentech - filed by Axicon Partners LLC. (Attachments: # 1 Proposed Order, # 2 Letter, # 3 Envelopes).(nms) Modified on 5/23/2024 (nms). (Entered: 05/23/2024) (0)
May 23, 2024 N/A Motions No Longer Referred: D.I. 93 MOTION to Supplement the Record with Delaware District Court Decision in Baxalta v. Genentech was referred in error by CM/ECF. (nms) (Entered: 05/23/2024) (0)
May 23, 2024 94 JOINT Claim Construction Chart, by United Therapeutics Corporation. (Attachments: # 1 Exhibit B, # 2 Exhibit C, # 3 Exhibit D)(Flynn, Michael) Modified on 5/24/2024 (nms). (Entered: 05/23/2024) (0)
May 16, 2024 91 NOTICE of Withdrawal of Motion (D.I. 90 ), by Axicon Partners LLC (nms) (Entered: 05/16/2024) (5)
May 16, 2024 92 NOTICE OF SERVICE of Defendant's First Set of Requests for the Production of Documents and Things to Plaintiff (Nos. 1 - 75) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 05/16/2024) (2)
May 15, 2024 90 MOTION for Leave to Submit a Letter Brief in Support of Liquidia's Opposition to United Therapeutic's Motion for a Preliminary Injunction - filed by Axicon Partners LLC. (Attachments: # 1 Exhibit 1, # 2 Proposed Order, # 3 Letter, # 4 Envelopes).(nms) Modified on 5/15/2024 (nms). (Entered: 05/15/2024) (0)
May 15, 2024 N/A Motions No Longer Referred: D.I. 90 MOTION for Leave to Submit a Letter Brief in Support of Liquidia's Opposition to United Therapeutic's Motion for a Preliminary Injunction is no longer referred to Magistrate Judge Sherry R. Fallon. The referral was made in error by CM/ECF. (nms) (Entered: 05/15/2024) (0)
May 13, 2024 89 NOTICE of Supplemental Authority by Liquidia Technologies, Inc. (Attachments: # 1 Exhibit 1)(Hoeschen, Nathan) (Entered: 05/13/2024) (0)
May 10, 2024 88 NOTICE of Supplemental Authority by Liquidia Technologies, Inc. (Attachments: # 1 Exhibit 1)(Hoeschen, Nathan) (Entered: 05/10/2024) (0)
May 7, 2024 87 RESPONSE to 77 MOTION for Leave to File a 1-Page Brief Responding to the Court's Questions at the Preliminary Injunction Hearing, filed by United Therapeutics Corporation. (Attachments: # 1 Exhibit A)(Flynn, Michael) Modified on 5/7/2024 (nms). (Entered: 05/07/2024) (0)
May 6, 2024 86 NOTICE OF SERVICE of Plaintiff United Therapeutics Corporation's First Set of Interrogatories to Defendant Liquidia Technologies, Inc. (No. 1) - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 05/06/2024) (3)
May 3, 2024 84 REDACTED VERSION of 79 Letter by United Therapeutics Corporation. (Flynn, Michael) (Entered: 05/03/2024) (4)
May 3, 2024 85 REDACTED VERSION of 78 Statement by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 05/03/2024) (11)
May 2, 2024 83 NOTICE OF SERVICE of Plaintiff United Therapeutics Corporation's Disclosure of Initial Infringement Contentions - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 05/02/2024) (3)
Apr 30, 2024 N/A Motions No Longer Referred: D.I. 81 Unopposed Motion to Keep Highly Confidential Information Under Seal is no longer referred to Magistrate Judge Sherry R. Fallon. This motion was referred in error by CM/ECF. (nms) (Entered: 04/30/2024) (0)
Apr 30, 2024 82 SO ORDERED Granting 81 Unopposed Motion to Keep Highly Confidential Information Under Seal. Signed by Judge Richard G. Andrews on 4/30/2024. (nms) (Entered: 04/30/2024) (4)
Apr 29, 2024 80 REDACTED VERSION of 53 Appendix - by United Therapeutics Corporation. (Attachments: # 1 Exhibits 1-20, # 2 Exhibits 21-39)(Flynn, Michael) (Entered: 04/29/2024) (0)
Apr 29, 2024 81 Unopposed Motion to Keep Highly Confidential Information Under Seal - filed by United Therapeutics Corporation. (Attachments: # 1 Exhibit A).(Flynn, Michael) Modified on 4/30/2024 (nms). (Entered: 04/29/2024) (0)
Apr 26, 2024 77 MOTION for Leave to File a 1-Page Brief Responding to the Court's Questions at the Preliminary Injunction Hearing - filed by Liquidia Technologies, Inc.. (Attachments: # 1 Proposed Order, # 2 Exhibit A)(Hoeschen, Nathan) Modified on 4/26/2024 (nms). (Entered: 04/26/2024) (0)
Apr 26, 2024 78 [SEALED] Response Regarding Bond Figures, by Liquidia Technologies, Inc.. (Attachments: # 1 Exhibit 1)(Hoeschen, Nathan) Modified on 4/26/2024 (nms). (Entered: 04/26/2024) (0)
Apr 26, 2024 79 [SEALED] Letter to The Honorable Richard G. Andrews, from Michael Flynn, regarding bond. (Flynn, Michael) Modified on 4/26/2024 (nms). (Entered: 04/26/2024) (0)
Apr 26, 2024 N/A Set Answering Brief Deadline re 77 MOTION for Leave to File a 1-Page Brief Responding to the Court's Questions at the Preliminary Injunction Hearing. Answering Brief/Response due date per Local Rules is 5/10/2024. (nms) (Entered: 04/29/2024) (0)
Apr 23, 2024 N/A Minute Entry for proceedings held before Judge Richard G. Andrews - Hearing regarding the Motion for Preliminary Injunction (D.I. 25 ) held on 4/23/2024. Counsel for Plaintiff: M. Flynn. Counsel for Defendant: K. Keller. (Court Reporter Heather Triozzi.) (lah) (Entered: 04/24/2024) (0)
Apr 22, 2024 72 ORAL ORDER: The redacted filing (D.I. 71 ) is REJECTED because parts of it are redacted in its entirety. Absent a compelling reason, supported by a statement under oath by a party, redactions in their entirety are impermissible; redactions must be done so as to redact the least possible amount of the materials submitted. Failure to make a good faith attempt at such redactions may result in sanctions, the most common of which would be simply unsealing the entire filing. Redacting in its entirety a document, or parts of it, that contains publicly available materials is prima facie evidence of bad faith. A revised redacted filing is DUE within five business days. Ordered by Judge Richard G. Andrews on 4/22/2024. (nms) (Entered: 04/22/2024) (0)
Apr 22, 2024 73 MOTION for Limited Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices - filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 4/22/2024 (nms). (Entered: 04/22/2024) (2)
Apr 22, 2024 74 REDACTED VERSION of 65 Reply Brief by United Therapeutics Corporation. (Flynn, Michael) (Entered: 04/22/2024) (20)
Apr 22, 2024 75 REDACTED VERSION of 66 Declaration by United Therapeutics Corporation. (Attachments: # 1 Exhibits 8-11, # 2 Exhibits 12-17, # 3 Exhibits 18-20)(Flynn, Michael) (Entered: 04/22/2024) (0)
Apr 22, 2024 N/A Motions No Longer Referred: D.I. 73 MOTION for Limited Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices is no longer referred to Magistrate Judge Sherry R. Fallon. The motion was referred in error by CM/ECF. (nms) (Entered: 04/22/2024) (0)
Apr 22, 2024 76 SO ORDERED Granting 73 MOTION for Limited Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices. Signed by Judge Richard G. Andrews on 4/22/2024. (nms) (Entered: 04/22/2024) (2)
Apr 19, 2024 70 REDACTED VERSION of 54 Declaration by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 04/19/2024) (30)
Apr 19, 2024 71 REDACTED VERSION of 53 Appendix by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 04/19/2024) (30)
Apr 18, 2024 68 REDACTED VERSION of 55 Declaration by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 04/18/2024) (30)
Apr 18, 2024 69 REDACTED VERSION of 52 Answering Brief in Opposition by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 04/18/2024) (30)
Apr 16, 2024 67 STIPULATION and Proposed Order to Extend Time to File Public Version of Defendant's Opposition to Motion for Preliminary Injunction (D.I. 52-55) to April 19, 2024 - filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 4/16/2024 (nms). (Entered: 04/16/2024) (1)
Apr 16, 2024 N/A SO ORDERED, re 67 STIPULATION and Proposed Order to Extend Time to File Public Version of Defendant's Opposition to Motion for Preliminary Injunction (D.I. 52-55) to April 19, 2024. Signed by Judge Richard G. Andrews on 4/19/2024. (nms) (Entered: 04/16/2024) (0)
Apr 15, 2024 65 [SEALED] REPLY BRIEF re 25 MOTION for Preliminary Injunction filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 04/15/2024) (0)
Apr 15, 2024 66 [SEALED] DECLARATION re 65 Reply Brief, by United Therapeutics Corporation. (Attachments: # 1 Exhibits 8-20)(Flynn, Michael) Modified on 4/16/2024 (nms). (Entered: 04/15/2024) (0)
Apr 8, 2024 63 Letter to The Honorable Richard G. Andrews, from Nathan R. Hoeschen, regarding specific description of what Liquidia has relied upon from United Therapeutics Corp. v. Liquidia Techs. Inc., C.A. No. 20-755-RGA (D. Del.). (Hoeschen, Nathan) Modified on 4/8/2024 (nms). (Entered: 04/08/2024) (5)
Apr 8, 2024 64 STIPULATION and Proposed Order to Extend Time to File Public Version of Defendant's Opposition to Motion for Preliminary Injunction (D.I. 52 - 55 ) to April 15, 2024 - filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 4/8/2024 (nms). (Entered: 04/08/2024) (1)
Apr 8, 2024 N/A SO ORDERED, re 64 STIPULATION and Proposed Order to Extend Time to File Public Version of Defendant's Opposition to Motion for Preliminary Injunction (D.I. 52 - 55 ) to April 15, 2024. Signed by Judge Richard G. Andrews on 4/8/2024. (nms) (Entered: 04/08/2024) (0)
Apr 5, 2024 60 ORAL ORDER: A hearing regarding the Motion for Preliminary Injunction (D.I. 25 ) is now set for 4/23/2024, at 3:00 PM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 4/5/2024. (nms) (Entered: 04/05/2024) (0)
Apr 5, 2024 61 NOTICE OF SERVICE of United Therapeutics Corporation's Initial Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 04/05/2024) (4)
Apr 5, 2024 62 NOTICE OF SERVICE of Defendant's Disclosures Under Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 04/05/2024) (2)
Apr 4, 2024 58 NOTICE to Take Deposition of Douglas Kidder on April 5, 2024 filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 04/04/2024) (3)
Apr 4, 2024 59 NOTICE to Take Deposition of Dr. Richard Channick on April 6, 2024 filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 04/04/2024) (3)
Apr 2, 2024 56 MOTION for Pro Hac Vice Appearance of Attorney Louis L. Lobel - filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 04/02/2024) (4)
Apr 2, 2024 57 Pro Hac Vice Fee - Credit Card Payment received for Louis L. Lobel. ( re 56 MOTION for Pro Hac Vice Appearance of Attorney Louis L. Lobel )( Payment of $ 50, receipt number ADEDC-4374650).(Flynn, Michael) (Entered: 04/02/2024) (0)
Apr 2, 2024 N/A SO ORDERED, re 56 MOTION for Pro Hac Vice Appearance of Attorney Louis L. Lobel, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 4/2/2024. (nms) (Entered: 04/02/2024) (0)
Apr 1, 2024 50 NOTICE OF SERVICE of Plaintiff United Therapeutics Corporation's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 04/01/2024) (4)
Apr 1, 2024 51 NOTICE OF SERVICE of Defendants Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) (Entered: 04/01/2024) (2)
Apr 1, 2024 52 [SEALED] ANSWERING BRIEF in Opposition re 25 MOTION for Preliminary Injunction filed by Liquidia Technologies, Inc..Reply Brief due date per Local Rules is 4/8/2024. (Hoeschen, Nathan) (Entered: 04/01/2024) (0)
Apr 1, 2024 53 [SEALED] Appendix to 52 Answering Brief in Opposition, by Liquidia Technologies, Inc.. (Attachments: # 1 Exhibits 1-20, # 2 Exhibits 21-39)(Hoeschen, Nathan) Modified on 4/2/2024 (nms). (Entered: 04/01/2024) (0)
Apr 1, 2024 54 [SEALED] DECLARATION re 52 Answering Brief in Opposition by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 04/01/2024) (0)
Apr 1, 2024 55 [SEALED] DECLARATION of Douglas Kidder re 52 Answering Brief in Opposition, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 4/2/2024 (nms). (Entered: 04/01/2024) (0)
Mar 21, 2024 49 NOTICE OF SERVICE of United Therapeutics Corporation's Initial Disclosures Pursuant to Paragraph 4 of the District of Delaware Default Standard for Discovery - filed by United Therapeutics Corporation.(Flynn, Michael) (Entered: 03/21/2024) (4)
Mar 15, 2024 N/A SO ORDERED, re 42 MOTION for Pro Hac Vice Appearance of Attorney Art Dykhuis, Adam W. Burrowbridge, Eric T. Romeo and Katherine Cheng, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 3/15/2024. (nms) (Entered: 03/15/2024) (0)
Mar 15, 2024 45 SCHEDULING ORDER: The matter will be referred to a magistrate judge to handle all discovery disputes. Joinder of Parties due by 4/4/2024. Amended Pleadings due by 4/4/2024. Discovery due by 11/13/2024. Joint Claim Construction Brief due by 8/29/2024. A Markman Hearing is set for 9/30/2024, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 6/13/2025, at 9:00 AM in Courtroom 6A. A 3-day Bench Trial is set to start 6/23/2025, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 3/15/2024. (nms) (Entered: 03/15/2024) (9)
Mar 15, 2024 46 ORAL ORDER: The Rule 16(b) Conference scheduled for 3/19/2024, is CANCELED. Ordered by Judge Richard G. Andrews on 3/15/2024. (nms) (Entered: 03/15/2024) (0)
Mar 15, 2024 N/A CASE REFERRED to Magistrate Judge Sherry R. Fallon to handle all discovery disputes including any that arise in connection with expert reports. (nms) (Entered: 03/15/2024) (0)
Mar 15, 2024 47 PROPOSED Stipulated Protective Order, by United Therapeutics Corporation. (Flynn, Michael) Modified on 3/15/2024 (nms). (Entered: 03/15/2024) (21)
Mar 15, 2024 48 SO ORDERED Granting 47 Stipulated Protective Order. Signed by Judge Richard G. Andrews on 3/15/2024. (nms) (Entered: 03/15/2024) (21)
Mar 14, 2024 42 MOTION for Pro Hac Vice Appearance of Attorney Art Dykhuis, Adam W. Burrowbridge, Eric T. Romeo and Katherine Cheng - filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 03/14/2024) (7)
Mar 14, 2024 43 Pro Hac Vice Fee - Credit Card Payment received for Art Dykhuis, Adam W. Burrowbridge, Eric T. Romeo, and Katherine Cheng. ( re 42 MOTION for Pro Hac Vice Appearance of Attorney Art Dykhuis, Adam W. Burrowbridge, Eric T. Romeo and Katherine Cheng )( Payment of $ 200, receipt number ADEDC-4362199).(Flynn, Michael) (Entered: 03/14/2024) (0)
Mar 14, 2024 44 PROPOSED Scheduling Order, by United Therapeutics Corporation. (Attachments: # 1 Letter)(Flynn, Michael) Modified on 3/15/2024 (nms). (Entered: 03/14/2024) (0)
Mar 11, 2024 N/A SO ORDERED, re 41 Stipulation and Proposed Order to Extend Time (*Reset Briefing Schedule: re 25 MOTION for Preliminary Injunction. Answering Brief due 4/5/2024, Reply Brief due 4/19/2024). Signed by Judge Richard G. Andrews on 3/11/2024. (nms) (Entered: 03/11/2024) (0)
Mar 8, 2024 N/A Pro Hac Vice Attorney Phillip E. Morton for Liquidia Technologies, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 03/08/2024) (0)
Mar 8, 2024 41 STIPULATION and Proposed Order to Extend Time, by Liquidia Technologies, Inc.. (DiBenedetto, Emily) Modified on 3/11/2024 (nms). (Entered: 03/08/2024) (3)
Mar 7, 2024 37 MOTION for Pro Hac Vice Appearance of Attorney Phillip E. Morton - filed by Liquidia Technologies, Inc.. (Keller, Karen) (Entered: 03/07/2024) (4)
Mar 7, 2024 38 Pro Hac Vice Fee - Credit Card Payment received for Phillip E. Morton. ( re 37 MOTION for Pro Hac Vice Appearance of Attorney Phillip E. Morton )( Payment of $ 50, receipt number ADEDC-4356074).(Keller, Karen) (Entered: 03/07/2024) (0)
Mar 7, 2024 39 NOTICE to Take Deposition of Steven D. Nathan, M.D. on March 10, 2024 filed by Liquidia Technologies, Inc..(Keller, Karen) (Entered: 03/07/2024) (2)
Mar 7, 2024 40 NOTICE to Take Deposition of Frederic Selck, Ph.D. on March 15, 2024 filed by Liquidia Technologies, Inc..(Keller, Karen) (Entered: 03/07/2024) (2)
Mar 7, 2024 N/A SO ORDERED, re 37 MOTION for Pro Hac Vice Appearance of Attorney Phillip E. Morton, filed by Liquidia Technologies, Inc.. Signed by Judge Richard G. Andrews on 3/7/2024. (nms) (Entered: 03/07/2024) (0)
Mar 4, 2024 N/A Pro Hac Vice Attorney Douglas H. Carsten for United Therapeutics Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) (Entered: 03/04/2024) (0)
Mar 4, 2024 33 REDACTED VERSION of 26 Opening Brief in Support by United Therapeutics Corporation. (Flynn, Michael) (Entered: 03/04/2024) (27)
Mar 4, 2024 34 REDACTED VERSION of 27 Declaration of Michael J. Flynn, by United Therapeutics Corporation. (Attachments: # 1 Exhibits 1-7)(Flynn, Michael) Modified on 3/5/2024 (nms). (Entered: 03/04/2024) (0)
Mar 4, 2024 35 REDACTED VERSION of 28 Declaration of Steven D. Nathan, M.D., by United Therapeutics Corporation. (Flynn, Michael) Modified on 3/5/2024 (nms). (Entered: 03/04/2024) (30)
Mar 4, 2024 36 REDACTED VERSION of 29 Declaration of Frederic Selck, Ph.D., by United Therapeutics Corporation. (Flynn, Michael) Modified on 3/5/2024 (nms). (Entered: 03/04/2024) (30)
Mar 1, 2024 N/A CORRECTING ENTRY: The proposed order filed at D.I. 33 has been removed from the docket per the filer's request. The filing was made in error and intended for another case. (mpb) Modified on 3/1/2024 (nms). (Entered: 03/01/2024) (0)
Feb 28, 2024 32 ANSWER to 12 Answer to Amended Complaint and Counterclaims, by United Therapeutics Corporation. (Attachments: # 1 Exhibits A-I)(Flynn, Michael) Modified on 2/28/2024 (nms). (Entered: 02/28/2024) (0)
Feb 27, 2024 30 ORAL ORDER: The motion for leave to file under seal (D.I. 23 ) is GRANTED but is subject to review once the redacted versions are filed. When the redacted version of the brief is filed, Plaintiff should provide a yellow-highlighted version for review. Over-redaction will result in summary unsealing of the brief. Ordered by Judge Richard G. Andrews on 2/27/2024. (nms) (Entered: 02/27/2024) (0)
Feb 27, 2024 31 Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 3/19/2024, at 2:00 PM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 2/27/2024. (nms) (Entered: 02/27/2024) (1)
Feb 26, 2024 23 Unopposed Motion for Leave to File Under Seal - filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 2/27/2024 (nms). (Entered: 02/26/2024) (6)
Feb 26, 2024 24 DECLARATION of Shaun R. Snader re 23 Unopposed Motion for Leave to File Under Seal, by United Therapeutics Corporation. (Flynn, Michael) Modified on 2/27/2024 (nms). (Entered: 02/26/2024) (4)
Feb 26, 2024 25 MOTION for Preliminary Injunction - filed by United Therapeutics Corporation. (Flynn, Michael) (Entered: 02/26/2024) (6)
Feb 26, 2024 26 [SEALED] OPENING BRIEF in Support re 25 MOTION for Preliminary Injunction, filed by United Therapeutics Corporation. Answering Brief/Response due date per Local Rules is 3/11/2024. (Flynn, Michael) Modified on 2/27/2024 (nms). (Entered: 02/26/2024) (0)
Feb 26, 2024 27 [SEALED] DECLARATION of Michael J. Flynn re 25 MOTION for Preliminary Injunction, by United Therapeutics Corporation. (Attachments: # 1 Exhibits 1-7)(Flynn, Michael) Modified on 2/27/2024 (nms). (Entered: 02/26/2024) (0)
Feb 26, 2024 28 [SEALED] DECLARATION of Steven D. Nathan, M.D. re 25 MOTION for Preliminary Injunction, by United Therapeutics Corporation. (Flynn, Michael) Modified on 2/27/2024 (nms). (Entered: 02/26/2024) (0)
Feb 26, 2024 29 [SEALED] DECLARATION of Frederic Selck, Ph.D. re 25 MOTION for Preliminary Injunction, by United Therapeutics Corporation. (Flynn, Michael) Modified on 2/27/2024 (nms). (Entered: 02/26/2024) (0)
Feb 23, 2024 21 MOTION for Pro Hac Vice Appearance of Attorney William C. Jackson of Goodwin Procter LLP and Douglas Carsten of McDermott Will & Emery LLP - filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 2/23/2024 (nms). (Entered: 02/23/2024) (5)
Feb 23, 2024 22 Pro Hac Vice Fee - Credit Card Payment received for William C. Jackson and Douglas Carsten. ( re 21 MOTION for Pro Hac Vice Appearance of Attorney William C. Jackson of GOODWIN PROCTER LLP and Douglas Carsten of MCDERMOTT WILL & EMERY LLP )( Payment of $ 100, receipt number ADEDC-4345783).(Flynn, Michael) (Entered: 02/23/2024) (0)
Feb 23, 2024 N/A SO ORDERED, re 21 MOTION for Pro Hac Vice Appearance of Attorney William C. Jackson of Goodwin Procter LLP and Douglas Carsten of McDermott Will & Emery LLP, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 2/23/2024. (nms) (Entered: 02/23/2024) (0)
Feb 1, 2024 N/A SO ORDERED, re 18 MOTION for Pro Hac Vice Appearance of Attorney Sanya Sukduang, Jonathan Davies, Adam Pivovar, Brittany Cazakoff, Rachel Preston, Lauren Strosnick, and Kyung Taeck Minn, filed by Liquidia Technologies, Inc.. Signed by Judge Richard G. Andrews on 2/1/2023. (nms) (Entered: 02/01/2024) (0)
Feb 1, 2024 N/A Pro Hac Vice Attorneys Kyung Taeck Minn, Rachel L. Preston, Sanya Sukduang, Lauren Strosnick, Brittany N. Cazakoff, Adam M. Pivovar, and Jonathan R. Davies for Liquidia Technologies, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/01/2024) (0)
Jan 31, 2024 18 MOTION for Pro Hac Vice Appearance of Attorney Sanya Sukduang, Jonathan Davies, Adam Pivovar, Brittany Cazakoff, Rachel Preston, Lauren Strosnick, and Kyung Taeck Minn - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 01/31/2024) (10)
Jan 31, 2024 19 Pro Hac Vice Fee - Credit Card Payment received for Sanya Sukduang, Jonathan Davies, Adam Pivovar, Brittany Cazakoff, and Rachel Preston. ( re 18 MOTION for Pro Hac Vice Appearance of Attorney Sanya Sukduang, Jonathan Davies, Adam Pivovar, Brittany Cazakoff, Rachel Preston, Lauren Strosnick, and Kyung Taeck Minn )( Payment of $ 250, receipt number ADEDC-4327380).(Hoeschen, Nathan) (Entered: 01/31/2024) (0)
Jan 31, 2024 20 Pro Hac Vice Fee - Credit Card Payment received for Lauren Strosnick and Kyung Taeck Minn. ( re 18 MOTION for Pro Hac Vice Appearance of Attorney Sanya Sukduang, Jonathan Davies, Adam Pivovar, Brittany Cazakoff, Rachel Preston, Lauren Strosnick, and Kyung Taeck Minn )( Payment of $ 100, receipt number ADEDC-4327396).(Hoeschen, Nathan) (Entered: 01/31/2024) (0)
Jan 22, 2024 N/A SO ORDERED, re 15 STIPULATION to Extend Time (*Reset Answer Deadlines: United Therapeutics Corporation answer due 2/28/2024). Signed by Judge Richard G. Andrews on 1/22/2024. (nms) (Entered: 01/22/2024) (0)
Jan 22, 2024 16 STIPULATION and [Proposed] Order of Partial Dismissal Without Prejudice by United Therapeutics Corporation. (Flynn, Michael) (Entered: 01/22/2024) (3)
Jan 22, 2024 17 SO ORDERED Granting 16 Stipulation and Proposed Order of Partial Dismissal Without Prejudice. Signed by Judge Richard G. Andrews on 1/22/2024. (nms) (Entered: 01/22/2024) (3)
Jan 19, 2024 15 STIPULATION to Extend Time - filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 1/22/2024 (nms). (Entered: 01/19/2024) (1)
Jan 8, 2024 12 ANSWER to 8 Amended Complaint and COUNTERCLAIMS against United Therapeutics Corporation, by Liquidia Technologies, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42)(Hoeschen, Nathan) Modified on 1/8/2024 (nms). (Entered: 01/08/2024) (0)
Jan 8, 2024 13 MOTION to Dismiss Counts I and II of Plaintiff's First Amended Complaint - filed by Liquidia Technologies, Inc.. (Attachments: # 1 Proposed Order)(Hoeschen, Nathan) Modified on 1/8/2024 (nms). (Entered: 01/08/2024) (0)
Jan 8, 2024 14 OPENING BRIEF in Support re 13 MOTION to Dismiss Counts I and II of Plaintiff's First Amended Complaint, filed by Liquidia Technologies, Inc..Answering Brief/Response due date per Local Rules is 1/22/2024. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Hoeschen, Nathan) Modified on 1/8/2024 (nms). (Entered: 01/08/2024) (0)
Dec 8, 2023 10 STIPULATION to Extend Time - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 12/8/2023 (nms). (Entered: 12/08/2023) (1)
Dec 8, 2023 11 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Liquidia Corporation for Liquidia Technologies, Inc. filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Entered: 12/08/2023) (2)
Dec 8, 2023 N/A SO ORDERED, re 10 STIPULATION to Extend Time (*Reset Answer Deadlines: Liquidia Technologies, Inc. answer due 1/16/2024). Signed by Judge Richard G. Andrews on 12/8/2023. (nms) (Entered: 12/08/2023) (0)
Nov 30, 2023 8 Amended Complaint* (1)
Nov 30, 2023 9 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,716,793 B2; 11,826,327 B2. (Flynn, Michael) Modified on 12/1/2023 (nms). (Entered: 11/30/2023) (1)
Nov 21, 2023 7 SUMMONS Returned Executed by United Therapeutics Corporation.Liquidia Technologies, Inc. served on 11/21/2023, answer due 12/12/2023. (Flynn, Michael) (Entered: 11/21/2023) (2)
Sep 13, 2023 N/A Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) (Entered: 09/13/2023) (0)
Sep 5, 2023 1 Complaint* (1)
Sep 5, 2023 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 09/06/2023) (3)
Sep 5, 2023 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/25/2023. Date of Expiration of Patent: 5/14/2027.Thirty Month Stay Deadline: 1/25/2026. (mpb) (Entered: 09/06/2023) (1)
Sep 5, 2023 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,716,793 B2. (mpb) (Entered: 09/06/2023) (1)
Sep 5, 2023 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent BlackRock Inc. filed by United Therapeutics Corporation. (mpb) (Entered: 09/06/2023) (2)
Sep 5, 2023 6 Summons Issued as to Liquidia Technologies, Inc. on 9/5/2023. (mpb) (Entered: 09/06/2023) (2)
Menu